Roche
RO.SW
#33
Rank
NZ$714.10 B
Marketcap
NZ$896.25
Share price
-0.64%
Change (1 day)
28.98%
Change (1 year)

EPS for Roche (RO.SW)

EPS in 2025: NZ$37.28

According to Roche's latest financial reports the company's current EPS (TTM) is NZ$37.28. In 2025 the company made an earnings per share (EPS) of NZ$37.28 an increase over its 2024 EPS that were of NZ$20.98.

EPS history for Roche from 1998 to 2025

Annual EPS

Year EPS Change
2025NZ$37.2877.67%
2024NZ$20.98-32.84%
2023NZ$31.251.95%
2022NZ$30.65-6.29%
2021NZ$32.70-5.53%
2020NZ$34.6216.56%
2019NZ$29.7030.3%
2018NZ$22.7920.22%
2017NZ$18.96-5.81%
2016NZ$20.134.62%
2015NZ$19.24-5.13%
2014NZ$20.28-25.05%
2013NZ$27.0621.73%
2012NZ$22.233.82%
2011NZ$21.418.16%
2010NZ$19.7923.72%
2009NZ$16.00-12.31%
2008NZ$18.24-0.34%
2007NZ$18.3132.13%
2006NZ$13.8642.56%
2005NZ$9.72-22.7%
2004NZ$12.57132.85%
2003NZ$5.40-150.87%
2002NZ-$10.61-209.09%
2001NZ$9.73-57.03%
2000NZ$22.6453.29%
1999NZ$14.7731.24%
1998NZ$11.26

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$12.19-67.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$9.58-74.31%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$1.30-96.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$4.93-86.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$31.71-14.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.61-90.31%๐Ÿ‡ซ๐Ÿ‡ท France
Becton Dickinson
BDX
NZ$6.57-82.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$1.81-95.14%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$5.25-85.92%๐Ÿ‡ฌ๐Ÿ‡ง UK